Açık Akademik Arşiv Sistemi

IL-6 mediated JAK/STAT3 signaling pathway in cancer patients with cachexia

IL-6 mediated JAK/STAT3 signaling pathway in cancer patients with cachexia

Guney G. Eskiler; Güney Eskiler, Gamze; E. Bezdegumeli; Z. Ozman; Deveci A. Ozkan; Deveci Özkan, Asuman; Bilir, Cemil; Bilir, Cemil; B. N. Kucukakca; M. N. Ince; A. Y. Men; O. Aktas; Y. E. Horoz; D. Akpinar
URI: https://doi.org/10.4149/BLL_2019_136
https://hdl.handle.net/20.500.12619/65641
Date: 2019

Abstract:

CONCLUSION: STAT3 may be considered as a therapeutic target for cachectic patients with gastric, lung and breast cancer. Furthermore, IL-6 mediates STAT3 activation in cachectic gastric and breast cancer patients (Tab. 5, Fig. 2, Ref. 62).

Show full item record

Files in this item

Icon
Name: 10.4149 BLL_2019_ ...
Size: 350.4Kb
Format: PDF
Description: Makale Dosyası
View/Open

This item appears in the following Collection(s)

info:eu-repo/semantics/openAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess